• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用星形胶质细胞模型破译拉佛拉病中的多聚糖醇积累。

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model.

机构信息

Instituto de Biomedicina de Valencia (IBV-CSIC), 46010 Valencia, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, 28029 Madrid, Spain.

出版信息

Int J Mol Sci. 2023 Mar 23;24(7):6020. doi: 10.3390/ijms24076020.

DOI:10.3390/ijms24076020
PMID:37046993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10094345/
Abstract

Lafora disease (LD) is a neurological disorder characterized by progressive myoclonus epilepsy. The hallmark of the disease is the presence of insoluble forms of glycogen (polyglucosan bodies, or PGBs) in the brain. The accumulation of PGBs is causative of the pathophysiological features of LD. However, despite the efforts made by different groups, the question of why PGBs accumulate in the brain is still unanswered. We have recently demonstrated that, in vivo, astrocytes accumulate most of the PGBs present in the brain, and this could lead to astrocyte dysfunction. To develop a deeper understanding of the defects present in LD astrocytes that lead to LD pathophysiology, we obtained pure primary cultures of astrocytes from LD mice from the postnatal stage under conditions that accumulate PGBs, the hallmark of LD. These cells serve as novel in vitro models for studying PGBs accumulation and related LD dysfunctions. In this sense, the metabolomics of LD astrocytes indicate that they accumulate metabolic intermediates of the upper part of the glycolytic pathway, probably as a consequence of enhanced glucose uptake. In addition, we also demonstrate the feasibility of using the model in the identification of different compounds that may reduce the accumulation of polyglucosan inclusions.

摘要

拉佛拉病(LD)是一种以进行性肌阵挛癫痫为特征的神经退行性疾病。该疾病的标志是脑内存在不溶性糖原形式(多葡聚糖体,或 PGBs)。PGBs 的积累是 LD 病理生理学特征的原因。然而,尽管不同的研究小组做出了努力,为什么 PGBs 在大脑中积累的问题仍然没有答案。我们最近证明,在体内,星形胶质细胞积累了大脑中存在的大部分 PGBs,这可能导致星形胶质细胞功能障碍。为了更深入地了解导致 LD 病理生理学的 LD 星形胶质细胞中存在的缺陷,我们从 LD 小鼠的出生后阶段获得了在积累 PGBs 的条件下产生的纯原代星形胶质细胞培养物,这是 LD 的标志。这些细胞为研究 PGBs 积累和相关 LD 功能障碍提供了新型的体外模型。从这个意义上说,LD 星形胶质细胞的代谢组学表明,它们积累了糖酵解途径上游的代谢中间产物,可能是由于增强的葡萄糖摄取所致。此外,我们还证明了该模型在鉴定可能减少多葡聚糖包涵体积累的不同化合物方面的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/a0c195b9227c/ijms-24-06020-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/42e9617c1da5/ijms-24-06020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/8b345b73c8d5/ijms-24-06020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/5f6d34a21c5e/ijms-24-06020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/b18c773d799c/ijms-24-06020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/34474aee4816/ijms-24-06020-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/c4284fdb5403/ijms-24-06020-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/a0c195b9227c/ijms-24-06020-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/42e9617c1da5/ijms-24-06020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/8b345b73c8d5/ijms-24-06020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/5f6d34a21c5e/ijms-24-06020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/b18c773d799c/ijms-24-06020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/34474aee4816/ijms-24-06020-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/c4284fdb5403/ijms-24-06020-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae3/10094345/a0c195b9227c/ijms-24-06020-g007.jpg

相似文献

1
Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model.利用星形胶质细胞模型破译拉佛拉病中的多聚糖醇积累。
Int J Mol Sci. 2023 Mar 23;24(7):6020. doi: 10.3390/ijms24076020.
2
Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.Lafora 病中星形胶质细胞和神经元产生不同类型的多聚葡聚糖体。
Glia. 2018 Oct;66(10):2094-2107. doi: 10.1002/glia.23463. Epub 2018 Aug 26.
3
Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.星形胶质细胞:Lafora 型进行性肌阵挛癫痫的新角色。
Hum Mol Genet. 2018 Apr 1;27(7):1290-1300. doi: 10.1093/hmg/ddy044.
4
Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.拉福拉病的发病机制:可溶性糖原向不溶性多聚葡萄糖的转变。
Int J Mol Sci. 2017 Aug 11;18(8):1743. doi: 10.3390/ijms18081743.
5
Polyglucosan body structure in Lafora disease.Lafora 病中的多聚葡聚糖体结构。
Carbohydr Polym. 2020 Jul 15;240:116260. doi: 10.1016/j.carbpol.2020.116260. Epub 2020 Apr 14.
6
Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease.瘦素信号抑制减少了拉佛拉病小鼠模型中的多聚糖包涵体和癫痫易感性。
Hum Mol Genet. 2017 Dec 15;26(24):4778-4785. doi: 10.1093/hmg/ddx357.
7
Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion.伴有EPM2B重复扩增的犬Lafora病中Laforin及其他相关蛋白的积累。
Vet Pathol. 2018 Jul;55(4):543-551. doi: 10.1177/0300985818758471. Epub 2018 Feb 14.
8
Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age.反应性神经胶质衍生的神经炎症:在拉福拉进行性肌阵挛性癫痫中随着年龄增长而进展的新特征。
Mol Neurobiol. 2020 Mar;57(3):1607-1621. doi: 10.1007/s12035-019-01842-z. Epub 2019 Dec 5.
9
Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.拉福林-马啉复合物与糖原脱支酶和脑型糖原磷酸化酶协同作用,降解多聚葡萄糖体。
Mol Neurobiol. 2014 Apr;49(2):645-57. doi: 10.1007/s12035-013-8546-z. Epub 2013 Sep 26.
10
The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.拉福拉病蛋白的碳水化合物结合结构域靶向拉福拉多聚葡萄糖体。
Biochem Biophys Res Commun. 2004 Jan 23;313(4):1101-9. doi: 10.1016/j.bbrc.2003.12.043.

引用本文的文献

1
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets.恩格列净用于拉福拉病的重新定位:一项试点临床试验及新型治疗靶点的临床前研究
Methods Protoc. 2025 May 6;8(3):48. doi: 10.3390/mps8030048.
2
H and P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease.氢质子磁共振波谱显示拉福拉病存在潜在的致病性和生物标志物代谢物改变。
Brain Commun. 2024 Mar 26;6(2):fcae104. doi: 10.1093/braincomms/fcae104. eCollection 2024.
3
The locus controls glycogen aggregation in astrocytes of the aged hippocampus without impacting cognitive function.

本文引用的文献

1
P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease.P-Rex1 是一种新型的 E3 泛素连接酶 Malin 的底物,与 Lafora 病有关。
Neurobiol Dis. 2023 Feb;177:105998. doi: 10.1016/j.nbd.2023.105998. Epub 2023 Jan 10.
2
TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy.TNF 和 IL6/Jak2 信号通路是 Lafora 病(一种进行性肌阵挛性癫痫的致命形式)中神经胶质细胞源性神经炎症的主要贡献者。
Neurobiol Dis. 2023 Jan;176:105964. doi: 10.1016/j.nbd.2022.105964. Epub 2022 Dec 14.
3
该基因座控制老年海马体星形胶质细胞中的糖原聚集,而不影响认知功能。
bioRxiv. 2024 Jul 8:2023.11.22.567373. doi: 10.1101/2023.11.22.567373.
Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease.
二甲双胍早期治疗改善拉佛拉病的神经结局。
Neurotherapeutics. 2023 Jan;20(1):230-244. doi: 10.1007/s13311-022-01304-w. Epub 2022 Oct 27.
4
AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.AAV 介导的人工 miRNA 减少成年多聚糖体和拉佛拉病小鼠模型中的致病性多聚糖体和神经炎症。
Neurotherapeutics. 2022 Apr;19(3):982-993. doi: 10.1007/s13311-022-01218-7. Epub 2022 Mar 28.
5
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.拉福拉病的自然病程:预后系统评价和个体参与者数据荟萃分析。
Orphanet J Rare Dis. 2021 Aug 16;16(1):362. doi: 10.1186/s13023-021-01989-w.
6
Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.二甲双胍对中枢神经系统的有益作用,重点关注癫痫和拉福拉病。
Int J Mol Sci. 2021 May 19;22(10):5351. doi: 10.3390/ijms22105351.
7
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review.AICAr,一种广泛使用的 AMPK 激活剂,具有重要的 AMPK 非依赖性作用:系统评价。
Cells. 2021 May 4;10(5):1095. doi: 10.3390/cells10051095.
8
Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.Gys1 反义疗法可挽救小鼠拉福拉病的神经病理学基础。
Brain. 2021 Nov 29;144(10):2985-2993. doi: 10.1093/brain/awab194.
9
Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease.谷氨酸转运体 1 的内吞作用受 laforin 和 malin 的调节:在 Lafora 病中的意义。
Glia. 2021 May;69(5):1170-1183. doi: 10.1002/glia.23956. Epub 2020 Dec 23.
10
Cellular and Molecular Mechanisms of Metformin Action.二甲双胍作用的细胞和分子机制。
Endocr Rev. 2021 Jan 28;42(1):77-96. doi: 10.1210/endrev/bnaa023.